ZWHC:CA:TSX-BMO Covered Call Health Care ETF (CAD)

ETF | Others |

Last Closing

CAD 29.4

Change

-0.33 (-1.11)%

Market Cap

N/A

Volume

324.00

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-03 )

Largest Industry Peers for Others

Symbol Name Price(Change) Market Cap
XEQT:CA iShares Core Equity Portfolio

+2.10 (+7.03%)

CAD 6.91B
CASH:CA GLOBAL X HIGH INTEREST SAVINGS..

+0.01 (+0.01%)

CAD 6.63B
XEF-U:CA iShares Core MSCI EAFE IMI Ind..

+1.55 (+6.05%)

CAD 6.19B
PHYS-U:CA Sprott Physical Gold Trust

+0.59 (+2.56%)

CAD 4.76B
XUS-U:CA iShares Core S&P 500 Index ETF

+2.96 (+9.42%)

CAD 4.54B
ZMMK:CA BMO Money Market Fund ETF Seri..

+0.01 (+0.02%)

CAD 4.20B
HXT-U:CA Global X S&P/TSX 60 Index ETF

+2.43 (+5.82%)

CAD 3.92B
CEF-U:CA Sprott Physical Gold and Silve..

+0.70 (+2.66%)

CAD 3.78B
PSLV-U:CA Sprott Physical Silver Trust

+0.26 (+2.59%)

CAD 3.29B
NSCB:CA NBI Sustainable Canadian Bond ..

-0.19 (-0.84%)

CAD 2.78B

ETFs Containing ZWHC:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (Others) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 1.94% 82% B 71% C-
Dividend Return N/A N/A N/A N/A N/A
Total Return 1.94% 81% B- 69% C-
Trailing 12 Months  
Capital Gain 1.38% 36% F 35% F
Dividend Return 3.86% 80% B- 69% C-
Total Return 5.24% 44% F 38% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 2.08% 41% F 39% F
Dividend Return 3.05% 43% F 36% F
Total Return 0.97% 82% B 38% F
Risk Return Profile  
Volatility (Standard Deviation) 4.55% 84% B 93% A
Risk Adjusted Return 67.04% 74% C 74% C
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

Low volatility

The stock’s annual returns have been stable and consistent compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile. Although stability is good, also keep in mind it can limit returns.

What to not like:
Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.